S32 — 2025 Investments

MedCrypt provides a cybersecurity toolkit for medical device manufacturers, helping their devices meet security regulations and detect malicious attacks.

CybersecurityDigital HealthHealthtechMedical DevicesSaaSSan Diego, US

EPEric Pancoast(CTO)inMKMike Kijewski(CEO)inVMVidya Murthy(VP of Operations)inWilliam Fenstermaker(Founder)Om Mahida(Engineer)Erin Murphree(talent acquisition)

Board seatACAndrew ConradMPMike Pellini· per SEC Form D

Co-investorsENEniac VenturesINIntuitive VenturesY Y CombinatorSESection 32ALAlumni VenturesANAnzu Partners+10 more

Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease.

BiotechDeep TechDigital HealthMedical DevicesSan Diego, US

ABAndrés Bratt-Leal(Co-Founder and Senior Vice President, Research & Development)inABANDRÉS BRATT-LEAL, Ph.D.(Co-Founder; Senior Vice President, Research & Development)DMDamien McDevitt(President and Chief Executive Officer)inDMDAMIEN MCDEVITT, Ph.D.(President and Chief Executive Officer)

Co-investorsARARCH Venture PartnersLILifeforce CapitalOROrbiMedDODomain AssociatesEDEDB InvestmentsSESection 32+10 more

AI research lab developing visual intelligence technology including image generation and manipulation models.

AI & Machine LearningDeep TechDeveloper ToolsFreiburg, DE

Robin Rombach(Founder)ABAndreas Blattmann(Founder)inPatrick Esser(Founder)Tim Dockhorn(Founder)

BoardAMAnjney Midha(Director)in

Co-investorsANAndreessen HorowitzBABain Capital VenturesBRBroadLight CapitalCHCherry VenturesEAEarlybird Venture CapitalHEHeadline+24 more

Character Bio is a patient-driven therapeutics company that combines genomics, longitudinal clinical and imaging data, and machine learning to identify genetic drivers of disease progression and develop new treatments, with a focus on polygenic diseases.

AI & Machine LearningBiotechDigital HealthJersey City, US

CZCheng Zhang(CEO, Co-Founder)inMarcel van der Brug(Scientific Advisor, Co-Founder)inNick Johnson(Technology Advisor, Co-Founder)inDEDaniel Elgort(Chief Data and Analytics Officer)inLCLaura Carter(Chief Scientific Officer)inRobert Kim(Chief Medical Officer)in

Co-investorsAMaMoonLULuma GroupSASanofi VenturesINInnovation EndeavorsCACantos VenturesCACatalio Capital Management, LP+5 more

Inductive Bio builds AI and machine learning software to accelerate drug discovery for pharmaceutical and biotech researchers, combining computational chemistry with expertise in translating complex drug programs from preclinical to clinical stages.

AI & Machine LearningBiotechDeep TechBrooklyn, US

JHJosh Haimson(Executive Officer, Director)inBBBen Birnbaum(Ph.D.)inATAlexander Taylor(Ph.D.)in

BoardRGRohan Ganesh(Director)in

Co-investorsALAlleyCorpAMAmino CollectiveANAndreessen HorowitzCOCoalition OperatorsENEnsemble LabsLULux Capital+6 more

Sola develops process automation software that uses bots to handle repetitive tasks, allowing teams to focus on higher-value work.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSNew York City, US

JWJessica Wu(Founder)inNDNeil Deshmukh(Founder)inBokang Sibolla(Founder)Rafic Melhem(Head of Engineering)Noah Patrick(Chief of Staff)Alex Kunze(Chief of Staff)

Co-investorsANAndreessen HorowitzCOConvictionGLGlilot Capital PartnersPIPioneerS S CapitalY Y Combinator+3 more

Sola is an AI-first enterprise security platform that connects a company's existing security and business tools to maintain a unified graph of identities, hosts, cloud resources, SaaS apps, and AI agents, letting practitioners query their stack in natural language and get evidenced answers.

AI & Machine LearningCybersecurityEnterprise SoftwareTel Aviv, IL

GFGuy Flechter(Founder)inRPRon Peled(Founder)inGuy Flechter Ron Peled(Founder)

Co-investorsGLGlilot Capital PartnersM1M12 (Microsoft's Venture Fund)NENew Era Capital PartnersS S CapitalSESeven Hill VenturesSESection 32+1 more